1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FIMDK |
Reimbursement information
Public price
CHF 238.15
Specialties list
Yes
Generic
No
SL addition date:
01/12/2004
Authorization holder
Gilead Sciences Switzerland Sàrl
6300 Zug
Authorization information
- Swissmedic authorization number
- 56880
- Drug name
- Emtriva, Kapseln
- Galenic form
- KAPS
- ATC Code
- J05AF09
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 25/10/2004
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- EMTRIVA caps 200 mg bte 30 pce
- Description (DE)
- EMTRIVA Kaps 200 mg Ds 30 Stk
- Market launch
- 25/10/2004
- Narcotic (BTM)
- No
Other package sizes (1)
None
None None
GTIN: None